We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
-0.83%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$158M
AUM Growth
+$316K
Cap. Flow
+$2.06M
Cap. Flow %
1.3%
Top 10 Hldgs %
22.5%
Holding
100
New
1
Increased
30
Reduced
41
Closed
3

Top Buys

Rank Stock Value
1
PX
Praxair Inc
PX
+$2.18M
2
MOS icon
The Mosaic Company
MOS
+$926K
3
AA icon
Alcoa
AA
+$165K
4
WMT icon
Walmart Inc
WMT
+$151K
5
COP icon
ConocoPhillips
COP
+$150K

Sector Composition

Rank Sector Weight
1 Industrials 17.2%
2 Technology 12.09%
3 Healthcare 11.04%
4 Financials 10.88%
5 Consumer Staples 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
26
CVS Health
CVS
$137B
$2.63M 1.67%
25,115
-630
-2% -$64.4K
MCD icon
27
McDonald's
MCD
$191B
$2.62M 1.66%
27,580
-390
-1% -$37.7K
WM icon
28
Waste Management
WM
$95.5B
$2.62M 1.66%
56,584
+2,520
+5% +$127K
CHRW icon
29
C.H. Robinson
CHRW
$21.8B
$2.5M 1.58%
40,052
+1,520
+4% +$100K
IJR icon
30
iShares Core S&P Small-Cap ETF
IJR
$110B
$2.34M 1.48%
39,668
+1,040
+3% +$61.5K
MOS icon
31
The Mosaic Company
MOS
$7.12B
$2.33M 1.48%
49,855
+20,400
+69% +$926K
COP icon
32
ConocoPhillips
COP
$142B
$2.3M 1.46%
37,530
+2,300
+7% +$150K
AA icon
33
Alcoa
AA
$11.6B
$2.28M 1.45%
85,214
+5,322
+7% +$165K
CMCSK
34
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$2.28M 1.44%
38,038
-530
-1% -$31.8K
CL icon
35
Colgate-Palmolive
CL
$73.6B
$2.24M 1.42%
34,280
+895
+3% +$60.7K
HYG icon
36
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$2.24M 1.42%
25,242
SPY icon
37
State Street SPDR S&P 500 ETF Trust
SPY
$787B
$2.21M 1.4%
10,712
-950
-8% -$200K
OMC icon
38
Omnicom Group
OMC
$23.3B
$2.18M 1.38%
31,359
+595
+2% +$44.9K
STT icon
39
State Street
STT
$51B
$2.16M 1.37%
28,116
+220
+0.8% +$17.1K
EEM icon
40
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$2.15M 1.36%
54,386
-258
-0.5% -$10.8K
PX
41
DELISTED
Praxair Inc
PX
$2.14M 1.36%
+17,910
New +$2.18M
BNY
42
Bank of New York Mellon
BNY
$108B
$2.14M 1.35%
51,000
-640
-1% -$27.3K
BBH icon
43
VanEck Biotech ETF
BBH
$398M
$2.07M 1.31%
15,388
-420
-3% -$55.8K
VB icon
44
Vanguard Small-Cap ETF
VB
$80.2B
$1.9M 1.2%
15,670
-250
-2% -$30.7K
ABT icon
45
Abbott
ABT
$180B
$1.76M 1.11%
35,854
+250
+0.7% +$12K
OIH icon
46
VanEck Oil Services ETF
OIH
$2.08B
$1.64M 1.04%
2,353
+185
+9% +$137K
CLX icon
47
Clorox
CLX
$11.7B
$1.54M 0.98%
14,838
-290
-2% -$31.3K
EFA icon
48
iShares MSCI EAFE ETF
EFA
$77.2B
$1.51M 0.95%
23,765
T icon
49
AT&T
T
$165B
$1.43M 0.91%
53,431
-1,682
-3% -$43.5K
AMLP icon
50
Alerian MLP ETF
AMLP
$12.8B
$1.42M 0.9%
18,240
+914
+5% +$76K

Similar funds

Boston Research & Management's Q2 2015 Portfolio in Review

As of Q2 2015, Boston Research & Management held 100 positions worth $158M, up 0.2% from $158M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 4%. Boston Research & Management opened 1 new position and exited 3, leaving the 100-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • Boston Research & Management's largest Q2 2015 buy was Praxair Inc: 17,910 shares worth $2.14M.
  • Boston Research & Management added most to The Mosaic Company in Q2 2015, an estimated $926K increase.
  • Boston Research & Management's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $200K.
  • Boston Research & Management fully exited Potash Corp Of Saskatchewan in Q2 2015, selling an estimated $977K.
  • Boston Research & Management's ten largest holdings make up 22% of its $158M portfolio in Q2 2015.
  • Boston Research & Management opened 1 new position and closed 3 in Q2 2015.
  • Boston Research & Management's portfolio value rose 0.2% quarter-over-quarter to $158M.

Based on Boston Research & Management's 13F filing for Q2 2015, filed 31 Jul 2015.